Pathstone Family Office’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $214K | Buy |
14,845
+412
| +3% | +$5.94K | ﹤0.01% | 1473 |
|
2023
Q2 | $237K | Buy |
14,433
+381
| +3% | +$6.26K | ﹤0.01% | 1071 |
|
2023
Q1 | $235K | Sell |
14,052
-13,310
| -49% | -$222K | ﹤0.01% | 1020 |
|
2022
Q4 | $411K | Buy |
27,362
+746
| +3% | +$11.2K | ﹤0.01% | 1178 |
|
2022
Q3 | $398K | Buy |
26,616
+13,710
| +106% | +$205K | ﹤0.01% | 1152 |
|
2022
Q2 | $212K | Buy |
12,906
+329
| +3% | +$5.41K | ﹤0.01% | 940 |
|
2022
Q1 | $252K | Buy |
12,577
+274
| +2% | +$5.49K | 0.01% | 819 |
|
2021
Q4 | $312K | Buy |
12,303
+238
| +2% | +$6.04K | 0.01% | 696 |
|
2021
Q3 | $326K | Buy |
12,065
+188
| +2% | +$5.08K | 0.01% | 650 |
|
2021
Q2 | $343K | Buy |
11,877
+182
| +2% | +$5.26K | 0.01% | 596 |
|
2021
Q1 | $308K | Buy |
11,695
+145
| +1% | +$3.82K | 0.01% | 475 |
|
2020
Q4 | $331K | Buy |
+11,550
| New | +$331K | 0.01% | 214 |
|